IVIG Dosage for ITP
For immune thrombocytopenia (ITP), the recommended IVIG dose is 0.8 to 1 g/kg as a single infusion, which has superseded the older regimen of 0.4 g/kg daily for 2-5 days. 11
Standard Dosing Regimen
The current evidence-based approach uses:
- Single dose: 0.8-1 g/kg administered as one infusion
- Alternative: 1 g/kg/day for 1-2 consecutive days (total 1-2 g/kg)
- Repeat dosing: Based on short-term platelet response if needed 111
This simplified regimen achieves response rates exceeding 80% in both adults and children, with most patients responding within 24-48 hours 11. The single higher dose (0.8-1 g/kg) is more convenient and equally effective compared to the historical multi-day lower dose regimen 1.
Infusion Rate
Initial rate: 0.01 mL/kg/min (0.5 mg/kg/min)
Maximum rate: 0.10 mL/kg/min (5 mg/kg/min) if tolerated 2
Monitor vital signs throughout infusion. If adverse reactions occur, slow or stop the infusion; resume at lower rate once symptoms subside 2.
Special Circumstances
Emergency/Life-Threatening Bleeding
In organ- or life-threatening situations, use IVIG in combination with:
- High-dose corticosteroids (e.g., methylprednisolone)
- Platelet transfusions (2-3 fold higher than usual dose)
- Consider IV anti-D if Rh(D)-positive 111
Dosing by Body Weight
Recent evidence suggests ideal body weight (IBW)-based dosing produces equivalent clinical outcomes to actual body weight dosing, with significant cost savings (average $5,231.87 per patient), without compromising early platelet response or length of stay 3. This is particularly relevant for obese patients.
Dose Limitations in High-Risk Patients
For patients at risk of thrombosis or renal dysfunction:
- Use minimum effective dose
- Infuse at minimum practicable rate (≤0.06 mL/kg/min or 3 mg/kg/min in elderly)
- Ensure adequate hydration before administration 22
Clinical Response Expectations
- Response rate: 80-90% of patients achieve platelet count >50 × 10⁹/L 11
- Time to response: Median 2 days (many within 24 hours) 45
- Duration: Typically transient, lasting 2-4 weeks; some patients maintain response for months 1
- Peak platelet count: Usually reached within 2-7 days 6
Pediatric Considerations
The same dosing applies to children: 0.8-1 g/kg as single dose 111. Lower doses (0.25-0.5 g/kg/day × 2 days) have shown efficacy in children under 5 years with fewer adverse events, though the standard 0.8-1 g/kg remains preferred for reliability 7.
Common Pitfalls
Avoid these errors:
- Using outdated multi-day low-dose regimens (0.4 g/kg × 5 days) - less convenient with no added benefit
- Infusing too rapidly in elderly or high-risk patients - increases thrombosis/renal failure risk
- Continuing IVIG beyond 1-2 days if adequate response achieved - unnecessary cost and exposure 1
- Dosing by actual body weight in obese patients - consider IBW dosing for cost-effectiveness 3
Key safety monitoring: